Caspase induction and BCL2 inhibition in human adipose tissue

Diabetes Care

Volumn 36, Issue 3, 2013, Pages 513-521

  Tinahones, Francisco José ^a,b   Araguez, Leticia CoIn ^a,b   Murri, Mora ^a,b   Olivera, Wilfredo Oliva ^a,b   Torres, Maria Dolores Mayas ^a,b   Barbarroja, Nuria ^a,c   Huelgas, Ricardo Gomez ^d   Malagón, Maria M ^a,e   Bekay, Rajaa El ^a,b  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^e UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CD11B ANTIGEN; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 3; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 6; LEPTIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE 1B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; APOPTOSIS; ARTICLE; BODY MASS; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; ENZYME INHIBITION; FAT MASS; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; MORBID OBESITY; MORBIDITY; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TISSUE CULTURE; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INTERLEUKIN-6; INTRA-ABDOMINAL FAT; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874432639     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0194     Document Type: Article

References (42)

1. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14:1132-1143
2. Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2005;2:105-112
3. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009;2:CD003641
4. Macias-Gonzalez M, Moreno-Santos I, Garc-ia-Almeida JM, Tinahones FJ, Garcia-Fuentes E. PPARgamma2 protects against obesity by means of a mechanism that mediates insulin resistance. Eur J Clin Invest 2009;39:972-979
5. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444:881-887
6. Bluher M. The distinction of metabolically 'healthy' from'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43
7. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 2010;51:3120-3127
8. Tan CY, Vidal-Puig A. Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. Biochem Soc Trans 2008;36:935-940
9. Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6:399-409
10. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S. Role of apoptosis in pancreatic beta-cell death in diabetes. Diabetes 2001;50 (Suppl.1):S44-S47
11. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326
12. Ashkenazi A, Holland P, Eckhardt SG. Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 2008;26: 3621-3630
13. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16
14. Logue SE, Martin SJ. Caspase activation cascades in apoptosis. Biochem Soc Trans 2008;36:1-9
15. Jakobi R. Subcellular targeting regulates the function of caspase-activated protein kinases in apoptosis. Drug Resist Updat 2004;7:11-17
16. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009;7:99-109
17. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46:2347-2355
18. Keuper M, Bluher M, Schön MR, et al. An inflammatory micro-environment promotes human adipocyte apoptosis. Mol Cell Endocrinol 2011;339:105-113
19. Sorisky A, Gagnon AM. Clinical implications of adipose tissue remodelling: adipogenesis and apoptosis. Canadian Journal of Diabetes 2002;26:232-240
20. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011;121:2094-2101
21. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367-377
22. Koenen TB, Stienstra R, van Tits LJ, et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes 2011; 60:517-524
23. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 1993;4:327-332
24. Alkhouri N, Gornicka A, Berk MP, et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 2010;285:3428-3438
25. Rosen EDP, Sarraf P, Troy AE, et al. PPAR g is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999;4:611-617
26. Guilherme A, Tesz GJ, Guntur KV, Czech MP. Tumor necrosis factor-alpha induces caspase-mediated cleavage of peroxisome proliferator-activated receptor gamma in adipocytes. J Biol Chem 2009;284: 17082-17091
27. Yang JY, Della-Fera MA, Baile CA. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells. Obesity (Silver Spring) 2008;16:16-22
28. Spalding KL, Arner E, Westermark PO, et al. Dynamics of fat cell turnover in humans. Nature 2008;453:783-787
29. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998; 95:9558-9561
30. Fern-andez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24:278-301
31. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-184
32. Prins JB, Niesler CU, Winterford CM, et al. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 1997;46:1939-1944
33. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95: 2409-2415
34. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
35. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-417
36. Bastard JP, Jardel C, Bruckert E, et al. Elevated levels of interleukin 6 are reduced in serumand subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000;85:3338-3342
37. Chiellini C, Bertacca A, Novelli SE, et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNFalpha. J Cell Physiol 2002;190: 251-258
38. Seto E, Usheva A, Zambetti GP, et al.Wildtype p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 1992;89:12028-12032
39. Mack DH, Vartikar J, Pipas JM, Laimins LA. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 1993;363:281-283
40. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008;9:402-412
41. Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009;15:1082-1087
42. Inoue N, Yahagi N, Yamamoto T, et al. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. J Biol Chem 2008;283:21220-21229